Cross-border
Private Equity
Bridge Point Private Equity focuses on investing in late-stage private healthcare companies that will benefit from penetrating the vast Chinese healthcare market.


Co-investment Platform
Bridge Point Co-investment Platform creates value through investing in exclusive early-stage private companies in the healthcare sector. We are structured as a "pledge-fund", offering our investors the option to participate in each fully underwritten deal led by a prestigious VC firm, providing unmatched flexibility and transparency.
Advisory
Bridge Point Advisory specializes in the commercialization of Western healthcare technology and products in the vast Chinese market by helping Chinese pharmaceutical companies obtain licensing deals with their Western counterparts.

Our People

Nadia Tian
MBA – Founding Partner

Gray Somers
Managing Director

Harry Edelson
CFA, CCP, CDP - Chairman of Advisory Board

John W. Allen
Member of Advisory Board

Chuck Clarvit
Member of Advisory Board
News/Press

Bridge Point Capital
info@bridgepoint.capital
1460 Broadway, 6th Floor, New York, NY 10036